观察研究
随机对照试验
医学
系统回顾
重症监护医学
出版偏见
梅德林
荟萃分析
内科学
政治学
法学
作者
Gordon Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Jan Brożek,Pablo Alonso‐Coello,Víctor M. Montori,Elie A. Akl,Ben Djulbegovic,Yngve Falck–Ytter
标识
DOI:10.1016/j.jclinepi.2010.07.017
摘要
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low-quality evidence, but both can be rated down if most of the relevant evidence comes from studies that suffer from a high risk of bias. Well-established limitations of randomized trials include failure to conceal allocation, failure to blind, loss to follow-up, and failure to appropriately consider the intention-to-treat principle. More recently recognized limitations include stopping early for apparent benefit and selective reporting of outcomes according to the results. Key limitations of observational studies include use of inappropriate controls and failure to adequately adjust for prognostic imbalance. Risk of bias may vary across outcomes (e.g., loss to follow-up may be far less for all-cause mortality than for quality of life), a consideration that many systematic reviews ignore. In deciding whether to rate down for risk of bias--whether for randomized trials or observational studies--authors should not take an approach that averages across studies. Rather, for any individual outcome, when there are some studies with a high risk, and some with a low risk of bias, they should consider including only the studies with a lower risk of bias.
科研通智能强力驱动
Strongly Powered by AbleSci AI